Ischemic Brain Injury in Hyperhomocysteinemia
- PMID: 34905309
- Bookshelf ID: NBK575734
- DOI: 10.36255/exonpublications.cerebralischemia.2021.hyperhomocysteinemia
Ischemic Brain Injury in Hyperhomocysteinemia
Excerpt
Homocysteine is an intermediate product of methionine metabolism. Hyperhomocysteinemia can be caused by high intake of methionine, deficiency of vitamin B12, folate, or both. Hyperhomocysteinemia causes cardio- and cerebrovascular diseases, including ischemic stroke. Hyperhomocysteinemia-induced oxidative stress, inflammation, and endoplasmic reticulum stress play an important role in the pathogenesis of several neurodegenerative diseases. Pyramidal neurons of the hippocampus are sensitive to prolonged levels of homocysteine due to the absence of metabolization by transsulfuration as well as by folate- or B12-dependent remethylation. This chapter highlights the role of hyperhomocysteinemia in neurodegenerative changes following cerebral ischemia. An overview of how hyperhomocysteinemia by itself, or in combination with ischemia-reperfusion injury, exacerbates neurodegeneration is presented. The role of hyperhomocysteinemia in amyloid deposition and hyperphosphorylation of tau protein in the brain, along with plasma metabolic alterations in cerebral ischemia-reperfusion injury is reviewed. Prevention of hyperhomocysteinemia may have therapeutic implications in cerebral ischemic stroke and deserves investigation.
Copyright: The Authors.; To the best of our knowledge, the materials included in this chapter do not violate copyright laws. All sources have been appropriately acknowledged and/or referenced. Where relevant, appropriate permissions have been obtained from the original copyright holder(s).
Conflict of interest statement
Sections
References
-
- Lehotský J, Burda J, Danielisová V, Gottlieb M, Kaplán P, Sániová B. Ischemic tolerance: the mechanisms of neuroprotective strategy. Anat Rec. 2009;292:2002–2012. https://doi.org/10.1002/ar.20970 . - DOI - PubMed
-
- Kwon HM, Lee YS, Bae HJ, Kang DW. Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke. Stroke. 2014;45(3):871–3. https://doi.org/10.1161/STROKEAHA.113.004099 . - DOI - PubMed
-
- Petras M, Tatarkova Z, Kovalska M, Mokra D, Dobrota D, Lehotsky J, et al. Hyperhomocysteinemia as a risk factor for the neuronal system disorders. J Physiol Pharmacol. 2014;65:15–23. - PubMed
-
- Herrmann W, Obeid R. Homocysteine: a biomarker in neurodegenerative diseases. Clin Chem Lab Med. 2011;49:435–441. https://doi.org/10.1515/CCLM.2011.084 . - DOI - PubMed
-
- Lehotský J, Tóthová B, Kovalská M, Dobrota D, Beňová A, Kalenská D, et al. Role of Homocysteine in the Ischemic Stroke and Development of Ischemic Tolerance. Front. Neurosci. 2016;10:538. https://doi.org/10.3389/fnins.2016.00538 . - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources